In addition to the degrees listed in the Education section above, Dr. Lam holds the following credentials: AAHIVP and FCSHP. Dr. Lam received her Bachelor of Arts degree from the University of California Los Angeles. She received her Doctor of Pharmacy degree from the University of Southern California (USC) School of Pharmacy. She completed a PGY1 residency at the San Francisco Veterans Affairs Health Care
Dr. Lam had established her ambulatory care practice sites at the Desert AIDS Project Clinic, Riverside Neighborhood Health Center and Perris Family Care Center clinics. She received the Preceptor of the Year in Ambulatory Care from LLU School of Pharmacy. Dr. Lam currently practices in a multidisciplinary medical team treating HIV and HIV/HCV coinfected patients at the AltaMed Medical Group in Santa Ana. Dr. Lam received the American Association of Colleges of Pharmacy (AACP)/Walmart Scholars Award as
Dr. Lam has authored multiple papers about HIV and Hepatitis C. She has been invited to speak on the topics of HIV, hepatitis C
Dr. Lam areas of research interest
Recent Creative, Scholarly Work and Publications
Lam JT, Marquez N, Nordt SP, Gutierrez MA. IPE Case Study and Guide – Infectious Diseases, Psychiatric Disorders
Lam JT, Holt C. Viral Hepatitis. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Zeind CS, Carvalho MG (Eds). Wolters Kluwer; 2017:1662-1692.
Lam JT, Lynch A, Gutierrez MA. Systemic Lupus Erythematous. In: Applied Therapeutics: The Clinical Use of Drugs, 11th ed., Zeind CS, Carvalho MG (Eds). Wolters Kluwer; 2017:700-714.
Gutierrez MA, Lam JT. Psychobiology and Psychopharmacology. In: Foundations of Psychiatric Mental Health Nursing, 8th ed., Halter MJ (Ed). Elsevier, St. Louis, Missouri; 2017:36-61.
Lam J, Goad J. The burden of vaccine-preventable diseases in adults. Pharmacy Times, March 31, 2017.
Jordan R, Lam JT, Lyren A, et al. Actionable Patient Safety Solution (APSS) #3A: Medication Errors. Patient Safety Movement Foundation. February 2017.
Lam JT, Peters C, Barker S, et al. Actionable Patient Safety Solution (APSS) #3B: Antimicrobial Stewardship: The Role of A Pharmacy And The Microbiology Lab In Patient Safety. Patient Safety Movement Foundation. January 2017.
Lam JT, Barker S, Ramsay M, et al. Actionable Patient Safety Solution (APSS) #3C: Improve Prevention of Severe Hypoglycemia. Patient Safety Movement Foundation. January 2017.
Yang S, Lam JT, Sims N, et al. Actionable Patient Safety Solution (APSS) #3D: Pediatric Adverse Drug Events. Patient Safety Movement Foundation. February 2017.
Lam JT, Salazar L. New combination antiviral for the treatment of hepatitis C. Am J Health-Syst Pharm 2016;73(14):1042-1050.
Lam JT, Yamaki J, Kayali Z. Advances in hepatitis C treatment: At the crossroads. J Nurse Pract. 2015;11:669-679.
Lam JT. Hepatitis C: In The Crosshairs. Chapman Living Textbook. Orange County Register. January 5, 2015. (http://www.ocregister.com/articles/treatment-647184-
Gutierrez MA, Lam JT,
Lam JT, Jacob S. Boceprevir: A new protease inhibitor for hepatitis C treatment. Am J Health-Syst Pharm. 2012;69:2135-2139.